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In humans, melanomas are found mostly in the epidermis, whereas mouse
melanomas are found in the dermis. It is, however, possible to force mouse
melanomas to develop more efficiently in the epidermis. The histological location
of a melanoma when discovered, whether in the epidermis or dermis, does not
necessarily reflect the location of the original cell.
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Melanomas are caused by genetic and/or
epigenetic modifications in melanocytes
in vivo. Such modifications can be
observed in biopsies from patients with
melanoma, in which the initial transfor-
mation occurred many cell divisions ear-
lier. Although the presence of genetic
modifications is not in itself evidence of
their causal role during melanomagenesis,
the generation and use of mutant mice
is a powerful approach in testing the
direct pathophysiological role of muta-
tions in vivo. Melanocytes may grow
abnormally in mouse mutants, and some
of the proliferating melanocytes may
transform into melanoma cells that can
metastasize. The relevance of such mod-
els to humans is a key issue in elucidating
the molecular, cellular, and histological
events that occur during melanomagen-
esis and to test new therapies. Evaluating
the relevance of any melanoma model
for humans is a difficult task for several
reasons, including the variability of mela-
noma biology in humans, the absence of
spontaneous melanomas in mice, and
clear differences in the structure of skin
in humans and mice.
The number of mouse melanoma
models has increased regularly in recent
years, and the models that are available
have become increasingly sophisticated
(for review see Larue and Beermann,
2007, and also see Delmas et al., 2007;
Dankort et al., 2009; Dhomen et al.,
2009; Damsky et al., 2011; Walker et al.,
2011; Rae et al., 2012). All of these
mouse melanoma models provide infor-
mation about the oncogenic function of
proteins of interest and are in most cases
relevant to human melanoma at the mole-
cular and cellular levels. In this issue,
Handoko et al. (2012) elegantly illustrate
this complexity with two models that are
apparently quite similar (Walker et al.,
2011; Rae et al., 2012). In both models,
KITL is expressed in keratinocytes under
the control of the K14 promoter (Kunisada
et al., 1998), and Map kinase is activated
constitutively. In one, an activated form
of Nras (NrasQ61K) begins to be expressed
during development, and in the other an
activated form of Braf (BrafV600E) is first
expressed after birth.
A major difference between these two
mouse melanoma models is that the
expansion of the melanoma occurs in
the dermis in one and in the epidermis
in the other.
Despite their dermal
location, mouse
melanomas are likely
to be of epidermal
origin.
Most human melanomas are thought
to be epidermal in origin and to invade
the dermis during progression, whereas
in mice they are ordinarily dermal in
origin. This suggests that the cells res-
ponsible for initiating mouse melanoma
See related article on pg 2299 were of dermal origin. The critical ques-
tion is whether this is always true, and
if so is there evidence to support this
concept?
The question at hand is the location of
the cell from which mouse melanomas
originate. There are few melanocytes in
the interfollicular epidermis and dermis
of 5-day-old mice. In fact, the largest
populations of melanocytes are in hair
follicles, which are epidermal appen-
dices, located in hair-covered parts of
the body. Mouse melanomas are most
likely to arise from hairy parts of the
body (mostly from follicular melano-
cytes), tail (mostly from epidermal mela-
nocytes), and ear pinnae (mostly from
dermal melanocytes). Melanomas occur
much more frequently in the hairy part
of the body than elsewhere. This may
reflect differences in the numbers of
melanocytes in these parts of the body
or in differences in the likelihood of
cells in each location to undergo trans-
formation. At this point, we have little
objective information about the propen-
sity of cell populations in such locations
to undergo transformation. However, it
may be argued that most mouse mela-
nomas are derived from the melano-
cytes that are located in hair follicles,
an epidermal appendage. These cells
are therefore most likely to be of epi-
dermal origin.
In most cases, the melanomas invade
the dermis relatively efficiently. Unfortu-
nately, pathologists analyze tumors only
after they have reached a certain size,
and, consequently, this happens after
a considerable number of tumor cell
divisions (and days or weeks) have trans-
pired. Moreover, histopathologic analysis
cannot be used to investigate the asso-
ciated dynamics and landmarks that
might suggest epidermal origin. These
most certainly would have disappeared
by the time.
When a strong chemoattractant, such
as KITL, is present in the epidermis,
melanoma-initiating cells are expected
to migrate superficially and to prolifer-
ate in a manner that leads to a ‘‘pseudo’’
superficial spreading melanoma. This
is the case for Arf / ::Tyr-NrasQ61K::
K14-Kitl. The melanoma-initiating cells
are subjected to two major influences.
KITL, which functions as a chemoattrac-
tant for melanocytes (and melanocyte
1Centre de Recherche, Developmental Genetics of Melanocytes, Institut Curie, Orsay, France; 2CNRS
UMR3347, Orsay, France and 3INSERM U1021, Orsay, France
Correspondence: Lionel Larue, Centre de Recherche, Developmental Genetics of Melanocytes, Institut
Curie, CNRS UMR3347, INSERM U1021, Orsay 91405 France. Email: lionel.larue@curie.fr
COMMENTARY
www.jidonline.org 2135
stem cells) during melanocyte develop-
ment and after birth, has an influence,
provided that KIT is present on the sur-
face of the tumor cells. The second
influence results from the induction of
the Map kinase pathway, via NRAS in
this case, which is known to induce
proliferation. In an NRAS-mutant (domi-
nant-active) background, the balance
between attraction and proliferation
results in both attraction in the epider-
mis and subsequent proliferation. The
melanoma-initiating cells then migrate
out from the hair follicle, being attracted
to KITL, and proliferate between kerati-
nocytes in the epidermis.
In the presence of a strong chemo-
attractant and a very strong oncogene
leading to massive proliferation, as for
BRAFV600E::K14-Kitl, the cells proliferate
in situ in the follicle and rapidly invade
the dermis. In a BRAF background, the
balance between attraction and proli-
feration leads to proliferation in situ
without migration toward the upper
layers of the skin and with destruction
of the basal layer separating the hair
follicle and the dermis. This might be
associated with a decrease in KIT levels
in the presence of BRAFV600E or with
other mechanisms.
Most melanocytes are located in hair
follicles, and the transformation of der-
mal or epidermal (interfollicular or folli-
cular) cells is, presumably, stochastic.
As such, mouse melanomas are much
more likely to arise from the epidermis
than from the dermis. Thus, despite their
dermal location, mouse melanomas are
likely to be of epidermal origin, and this
should not be forgotten when interpret-
ing the results of studies using mouse
melanoma models.
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